NetherlandsOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 3,466 out of 235,606 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 110,290 | 111,326 |
| Total Cites | 16,213 | 18,831 |
| H-index | 69 | 75 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 2,543 | 2,942 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 6,385 | 7,419 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12,033 | 13,007 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.45 |
| Self-Citation Percentage |
13.90%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1,147 out of 103,235 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 124,716 | 124,665 |
| Total Cites | 10,403 | 12,465 |
| H-index | 57 | 65 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 2,171 | 2,546 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 4,785 | 5,711 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,485 | 8,167 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.53 |
| Self-Citation Percentage |
16.54%
|
|
United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1,097 out of 89,177 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 124,698 | 122,229 |
| Total Cites | 9,604 | 11,604 |
| H-index | 56 | 64 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 2,081 | 2,452 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 4,540 | 5,457 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,877 | 7,524 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.54 |
| Self-Citation Percentage |
17.24%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1,086 out of 75,210 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 129,980 | 129,320 |
| Total Cites | 7,842 | 9,543 |
| H-index | 49 | 56 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1,941 | 2,284 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 3,976 | 4,798 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,526 | 6,042 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.58 |
| Self-Citation Percentage |
17.82%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.